News
HepaRegeniX GmbH ("HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease ...
KØBENHAVN, DK / ACCESS Newswire / June 10, 2025 / FluoGuide A/S (STO:FLUO) - Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback